Related references
Note: Only part of the references are listed.Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma
Kasthuri Kannan et al.
Oncotarget (2015)
Histone deacetylase inhibitor AR42 regulates telomerase activity in human glioma cells via an Akt-dependent mechanism
Ya-Luen Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Chromatin Remodeling Defects in Pediatric and Young Adult Glioblastoma: A Tale of a Variant Histone 3 Tail
Adam M. Fontebasso et al.
BRAIN PATHOLOGY (2013)
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
Eric Letouze et al.
CANCER CELL (2013)
Chromatin Regulator PRC2 Is a Key Regulator of Epigenetic Plasticity in Glioblastoma
Atsushi Natsume et al.
CANCER RESEARCH (2013)
Influence of Metabolism on Epigenetics and Disease
William G. Kaelin et al.
CELL (2013)
Targeting histone modifications - epigenetics in cancer
Tanja Waldmann et al.
CURRENT OPINION IN CELL BIOLOGY (2013)
Histone 3 Lysine 9 Trimethylation Is Differentially Associated With Isocitrate Dehydrogenase Mutations in Oligodendrogliomas and High-Grade Astrocytomas
Sriram Venneti et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
DNA methylation dynamics in health and disease
Yehudit Bergman et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
Peter W. Lewis et al.
SCIENCE (2013)
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Dan Rohle et al.
SCIENCE (2013)
DNA Hypermethylation and Histone Modifications Downregulate the Candidate Tumor Suppressor Gene RRP22 on 22q12 in Human Gliomas
Natalie Schmidt et al.
BRAIN PATHOLOGY (2012)
Molecular pathogenesis of IDH mutations in gliomas
Koichi Ichimura
BRAIN TUMOR PATHOLOGY (2012)
Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients
Akitake Mukasa et al.
CANCER SCIENCE (2012)
The Promoter Hypermethylation Status of GATA6, MGMT, and FHIT in Glioblastoma
Gulsah Cecener et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2012)
Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results
Sharon Berendsen et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
IDH mutations in acute myeloid leukemia
Dinesh Rakheja et al.
HUMAN PATHOLOGY (2012)
HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
Omar Khan et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Targeting the enhancer of zeste homologue 2 in medulloblastoma
Irina Alimova et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The Capicua repressor - a general sensor of RTK signaling in development and disease
Gerardo Jimenez et al.
JOURNAL OF CELL SCIENCE (2012)
P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells
K. Bajbouj et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact
Joshua C. Black et al.
MOLECULAR CELL (2012)
Landscape of TET2 mutations in acute myeloid leukemia
S. Weissmann et al.
LEUKEMIA (2012)
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Sevin Turcan et al.
NATURE (2012)
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Jeremy Schwartzentruber et al.
NATURE (2012)
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
Gang Wu et al.
NATURE GENETICS (2012)
Targeting Epigenetic Readers in Cancer
Mark A. Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity
Hak Jae Kim et al.
RADIATION ONCOLOGY (2012)
Genetically-defined metabolic reprogramming in cancer
Andrew R. Mullen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
A focus on the preclinical development and clinical status of the histone deacetylase inhibitor, romidepsin (depsipeptide, Istodax®)
Simon J. Harrison et al.
EPIGENOMICS (2012)
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
Yuchen Jiao et al.
ONCOTARGET (2012)
p53 in trichostatin A induced C6 glioma cell death
Ya-Fen Hsu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2011)
POTEH hypomethylation, a new epigenetic biomarker for glioma prognosis
Xiaoping Liu et al.
BRAIN RESEARCH (2011)
Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
Wei Xu et al.
CANCER CELL (2011)
A Developmental Taxonomy of Glioblastoma Defined and Maintained by MicroRNAs
Tae-Min Kim et al.
CANCER RESEARCH (2011)
Regulation of chromatin by histone modifications
Andrew J. Bannister et al.
CELL RESEARCH (2011)
Epigenetic-Based Therapies in Cancer Progress to Date
Sang-Hyun Song et al.
DRUGS (2011)
DNMT3B Gene Amplification Predicts Resistance To DNA Demethylating Drugs
Laia Simo-Riudalbas et al.
GENES CHROMOSOMES & CANCER (2011)
Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin
Albert Lai et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas
Ganeshkumar Rajendran et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?
Nanne K. Kloosterhof et al.
LANCET ONCOLOGY (2011)
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D. Morin et al.
NATURE (2011)
Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia
Xiao-Jing Yan et al.
NATURE GENETICS (2011)
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
Jason W. Locasale et al.
NATURE GENETICS (2011)
Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells
F. Orzan et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2011)
Quantitative Characterization of the Interactions among c-myc Transcriptional Regulators FUSE, FBP, and FIR
Hsin-hao Hsiao et al.
BIOCHEMISTRY (2010)
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Houtan Noushmehr et al.
CANCER CELL (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Global Histone Modification Patterns as Prognostic Markers to Classify Glioma Patients
Bo-lin Liu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Current and Emerging Treatment Strategies for Cutaneous T-cell Lymphoma
Frederick Lansigan et al.
DRUGS (2010)
HDAC inhibitor, scriptaid, induces glioma cell apoptosis through JNK activation and inhibits telomerase activity
Vivek Sharma et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Trichostatin A Stimulates Steroid 5α-Reductase Gene Expression in Rat C6 Glioma Cells via a Mechanism Involving Sp1 and Sp3 Transcription Factors
Song Her et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2010)
Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
Gorica Nikoloski et al.
NATURE GENETICS (2010)
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Thomas Ernst et al.
NATURE GENETICS (2010)
DNMT3A Mutations in Acute Myeloid Leukemia.
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
Christian Hartmann et al.
ACTA NEUROPATHOLOGICA (2009)
Antitumor Effects of a Combined 5-Aza-2′Deoxycytidine and Valproic Acid Treatment on Rhabdomyosarcoma and Medulloblastoma in Ptch Mutant Mice
Ines Ecke et al.
CANCER RESEARCH (2009)
EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
Mario-Luca Suva et al.
CANCER RESEARCH (2009)
Unsupervised Analysis of Transcriptomic Profiles Reveals Six Glioma Subtypes
Aiguo Li et al.
CANCER RESEARCH (2009)
A microarray-based DNA methylation study of glioblastoma multiforme
Ramon Martinez et al.
EPIGENETICS (2009)
Loss of NECL1, a Novel Tumor Suppressor, Can be Restored in Glioma by HDAC Inhibitor-Trichostatin A Through Sp1 Binding Site
Jing Gao et al.
GLIA (2009)
IDH1 Mutations at Residue p.R132 (IDH1R132) Occur Frequently in High-Grade Gliomas But Not in Other Solid Tumors
Fonnet E. Bleeker et al.
HUMAN MUTATION (2009)
Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors
Hemant Sarin
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
Gijs van Haaften et al.
NATURE GENETICS (2009)
Mutation in TET2 in Myeloid Cancers
Francois Delhommeau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
GSK3β Regulates Differentiation and Growth Arrest in Glioblastoma
Serdar Korur et al.
PLOS ONE (2009)
Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma
Maria Berdasco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Analysis of the IDH1 codon 132 mutation in brain tumors
Joerg Balss et al.
ACTA NEUROPATHOLOGICA (2008)
Copy number alterations of the polycomb gene BMI1 in gliomas
Valtteri Hayry et al.
ACTA NEUROPATHOLOGICA (2008)
Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue:: class II and IV are hypoexpressed in glioblastomas
Agda Kb Lucio-Eterovic et al.
BMC CANCER (2008)
Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells
Jeongwu Lee et al.
CANCER CELL (2008)
Cancer cell metabolism: Warburg and beyond
Peggy P. Hsu et al.
CELL (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
MLL translocations, histone modifications and leukaemia stem-cell development
Andrei V. Krivtsov et al.
NATURE REVIEWS CANCER (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Downregulation of RUNX3 and TES by hypermethylation in glioblastoma
W. Mueller et al.
ONCOGENE (2007)
Polycomb silencers control cell fate, development and cancer
Anke Sparmann et al.
NATURE REVIEWS CANCER (2006)
Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma
Susan E. Spiller et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma
Greg Foltz et al.
CANCER RESEARCH (2006)
Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275
LY Eyüpoglu et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Curcumin-induced histone hypoacetylation enhances caspase-3-dependent glioma cell death and neurogenesis of neural progenitor cells
SK Kang et al.
STEM CELLS AND DEVELOPMENT (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Histone demethylation by a family of JmjC domain-containing proteins
Y Tsukada et al.
NATURE (2006)
Histone H4-K16 acetylation controls chromatin structure and protein interactions
M Shogren-Knaak et al.
SCIENCE (2006)
Genomic DNA methylation: the mark and its mediators
RJ Klose et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Methylation of tRNAAsP by the DNA methyltransferase homolog Dnmt2
MG Goll et al.
SCIENCE (2006)
A family of human zinc finger proteins that bind methylated DNA and repress transcription
GJP Filion et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma
M Alaminos et al.
CANCER RESEARCH (2005)
Reading signals on the nucleosome with a new nomenclature for modified histones
BM Turner
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
The SET-domain protein superfamily: protein lysine methyltransferases
SC Dillon et al.
GENOME BIOLOGY (2005)
Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas
L Hesson et al.
ONCOGENE (2004)
The nucleosome: From genomic organization to genomic regulation
S Khorasanizadeh
CELL (2004)
Histone demethylation mediated by the nuclear arnine oxidase homolog LSD1
YJ Shi et al.
CELL (2004)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Histone deacetylase inhibitors in cancer therapy: Is transcription the primary target?
RW Johnstone et al.
CANCER CELL (2003)
Acetylation inactivates the transcriptional repressor BCL6
OR Bereshchenko et al.
NATURE GENETICS (2002)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer
IPM Tomlinson et al.
NATURE GENETICS (2002)
Dnmt3L and the establishment of maternal genomic imprints
D Bourc'his et al.
SCIENCE (2001)
Regulation of chromatin structure by site-specific histone H3 methyltransferases
S Rea et al.
NATURE (2000)
Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma
BE Baysal et al.
SCIENCE (2000)
The language of covalent histone modifications
BD Strahl et al.
NATURE (2000)
Share Paper
